Browsing Tag
Novartis Canada
1 post
Can asciminib reshape first-line CML treatment? Inside Scemblix’s rise as a new standard of care in Canada
More than a month after Health Canada’s approval, Scemblix is forcing a rethink of chronic myeloid leukemia therapy—and raising the bar for tolerability and precision.